The sickle cell treatments available before Casgevy focused on symptom management such as reducing the frequency of ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Cancer cells thrive in an environment deprived of oxygen and nutrients, adapting to survive and grow. Unlike normal cells, ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

Since their discovery, the stem cell (SC) field achieved significant milestones and opened several gateways in the area of disease modeling, drug discovery, and regenerative medicine. In parallel, the ...

Stem cells are rare in the body and require specific conditions to stay alive ... It is working closely with one of the leaders of gene editing, CRISPR Therapeutics. They are working on Sickle cell ...